Video: Day 3 Highlights | ACC.19

Drs. Kim Eagle, Deepak Bhatt, and Peter Block discuss acute aortic dissection in 9000 patients (IRAD – 00:37); reduction in total ischemic events with icosapent ethyl (REDUCE-IT Total Events – 03:16); dapagliflozin on HF and mortality in diabetes based on EF (DECLARE-TIMI 58 – 05:27); and femoral access vs. radial access for primary PCI in STEMI (SAFARI-STEMI – 07:15). Visit http://acc.org/ACC19 for full meeting coverage.


Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Prevention, Anticoagulation Management and ACS, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Hypertriglyceridemia, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Interventions and ACS, Hypertension, Smoking

Keywords: ACC Annual Scientific Session, ACC19, EaglesEyeView, Amputation, Atherosclerosis, Diabetic Ketoacidosis, Diabetes Mellitus, Type 2, Brain Ischemia, Dyslipidemias, Heart Failure, Glycated Hemoglobin A, Hyperglycemia, Hypertension, Metabolic Syndrome, Myocardial Ischemia, Myocardial Infarction, Primary Prevention, Renal Insufficiency, Chronic, Stroke, Stroke Volume, Smoking, Vascular Diseases, Benzhydryl Compounds, Angina, Unstable, Atrial Fibrillation, Cholesterol, HDL, Cholesterol, LDL, Diabetes Mellitus, Eicosapentaenoic Acid, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypertriglyceridemia, Myocardial Revascularization, Triglycerides, Secondary Prevention, Acute Coronary Syndrome, Aspirin, Heparin, Medical Futility, Peptide Fragments, Percutaneous Coronary Intervention, Stents, Thrombosis, Vascular Closure Devices


< Back to Listings